You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-interleukin -5

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

Completed
  • Pleural Mesothelioma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP

Recruiting
  • Nasal Polyps
  • Aspirin-exacerbated Respiratory Disease
  • Non-Interventional
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jan 5, 2023

B-Cell Leukemia, B-Cell Lymphoma Trial in Guangzhou (4SCAR19/22 T cells, Interleukin-2)

Suspended
  • B-Cell Leukemia
  • B-Cell Lymphoma
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Aug 9, 2021

Anti-aging Trial in Rio De Janeiro (Topical serum)

Completed
  • Anti-aging
  • Topical serum
  • Rio De Janeiro, Brazil
    CIDP Brasil
Sep 28, 2023

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Metastatic Uveal Melanoma
  • Aldesleukin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

HIV Trial in Durham (Zidovudine, Aldesleukin)

Completed
  • HIV Infections
  • Durham, North Carolina
    Duke Univ. Med. Ctr. Adult CRS
Oct 28, 2021

COVID-19 Trial in Los Angeles (Clazakizumab)

Completed
Has Results
  • COVID-19
  • Los Angeles, California
    Cedars-Sinai Medical Center
Nov 30, 2021

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Anti-GPRC5D CAR-T Cells Injection)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • Anti-GPRC5D CAR-T Cells Injection
  • (no location specified)
Feb 18, 2023

HIV Trial in Bangkok (Aldesleukin, ART)

Completed
  • HIV Infections
  • Bangkok, Ratchathewi, Thailand
  • +1 more
Oct 27, 2021

Solid Tumor, Sars-CoV2, Hematological Malignancy Trial in New York (BMS-986253)

Terminated
  • Solid Tumor
  • +2 more
  • New York, New York
    Columbia University Irving Medical Center
Nov 18, 2021

HIV Trial in Houston (Aldesleukin)

Completed
  • HIV Infections
  • Houston, Texas
    Thomas Street Clinic C605-020 CRS
Oct 27, 2021

Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

Not yet recruiting
  • Pericarditis
  • IL1RA Antibody Assay
  • suPAR Testing
  • Homburg, Germany
  • +8 more
Jun 22, 2023

Diabetes, Type 1, Hypoglycemia, Autoimmune Diseases Trial in Miami (Anti-Thymocyte Globulin (ATG), Interleukin 2, Exenatide)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • +3 more
  • Anti-Thymocyte Globulin (ATG)
  • +7 more
  • Miami, Florida
    Diabetes Research Institute, University of Miami Miller School o
Feb 23, 2022

Atypical Hemolytic Uremic Syndrome Trial (Iptacopan)

Not yet recruiting
  • Atypical Hemolytic Uremic Syndrome
  • (no location specified)
Jun 29, 2023

HIV-1-infection Trial in New York, Philadelphia, Nashville (INO-6160, 2 mg, Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500

Recruiting
  • HIV-1-infection
  • INO-6160, 2 mg
  • Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500 mcg)
  • New York, New York
  • +2 more
Apr 13, 2023

HIV Trial in Chicago, Durham, Galveston (Interleukin-12, HIV-1 C4-V3 Polyvalent Peptide Vaccine)

Completed
  • HIV Infections
  • Chicago, Illinois
  • +2 more
Oct 28, 2021

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Kunming (Anti-GPRC5D CAR-T cells infusion)

Recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • Anti-GPRC5D CAR-T cells infusion
  • Kunming, Yunnan, China
  • +1 more
Feb 21, 2023

Multiple Myeloma Trial in Xuzhou (anti-BCMA/GPRC5D CAR-T CELL)

Recruiting
  • Multiple Myeloma
  • anti-BCMA/GPRC5D CAR-T CELL
  • Xuzhou, Jiangsu, China
    Kailin Xu
Aug 19, 2022

Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte

Active, not recruiting
  • Adult Acute Myeloid Leukemia in Remission
  • +12 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Toripalimab (anti-programmed death-1 inhibitor),

Recruiting
  • Oral Squamous Cell Carcinoma
  • +3 more
  • Toripalimab (anti-programmed death-1 inhibitor)
  • +4 more
  • Shanghai, Shanghai, China
    Ninth People's Hospital, Shanghai Jiao Tong University School of
Oct 8, 2022

Crohn Disease Trial in Evansville (JNJ-64304500, Placebo, Adalimumab)

Withdrawn
  • Crohn Disease
  • Evansville, Indiana
    Medisphere Medical Research Center, Llc
Aug 30, 2021

Anti-IL-6 Receptor Monoclonal Antibodies on Treatment of

Recruiting
  • Rheumatoid Arthritis
  • +3 more
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Apr 25, 2022

    Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV Trial in Jerusalem (CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide,

    Recruiting
    • Sarcoma, Synovial
    • +8 more
    • CYCLOPHOSPHAMIDE and FLUDARABIN
    • +3 more
    • Jerusalem, Israel
      Hadassah Medical Organization
    Mar 15, 2022

    Respiratory Syncytial Virus Infections Trial in Japan (Nirsevimab)

    Recruiting
    • Respiratory Syncytial Virus Infections
    • Bunkyo-ku, Japan
    • +11 more
    Sep 11, 2023

    Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

    Recruiting
    • Depressive Disorder, Major
    • +2 more
    • New Haven, Connecticut
      Yale University
    Aug 8, 2022